The contribution of hypothalamic neuroendocrine, neuroplastic and neuroinflammatory processes to lipopolysaccharide-induced depressive-like behaviour in female and male rats: Involvement of glucocorticoid receptor and C/EBP-β

Behavioural Brain Research

Volumn 291, Issue , 2015, Pages 130-139

  Adzic, Miroslav ^a   Djordjevic, Jelena ^a   Mitic, Milos ^a   Brkic, Zeljka ^a   Lukic, Iva ^a   Radojcic, Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

C EBP ; Depressive like behaviour; Glucocorticoid receptor; Hypothalamus; Lypopolysaccharide (LPS); Sex

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CCAAT ENHANCER BINDING PROTEIN BETA; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; CEBPB PROTEIN, RAT; PTGS2 PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CELL NUCLEUS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOPLASM; CYTOSOL; DEPRESSION; FEMALE; GENE EXPRESSION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILITY; MALE; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SUCROSE PREFERENCE TEST; ANIMAL; DISEASE MODEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOMODULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; WISTAR RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; CYCLOOXYGENASE 2; CYTOSOL; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPOPOLYSACCHARIDES; MALE; NEUROIMMUNOMODULATION; NF-KAPPA B; PITUITARY-ADRENAL SYSTEM; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; SEX CHARACTERISTICS;

EID: 84930626972     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.05.029     Document Type: Article

References (60)

1. Maes M. Psychological stress and the inflammatory response system. Clin. Sci. (Lond.) 2001, 101:193-194.
2. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 2001, 15:199-226.
3. Connor T.J., Leonard B.E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998, 62:583-606.
4. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 1999, 45:833-839.
5. Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur. Neuropsychopharmacol. 2001, 11:203-208.
6. Pollak Y., Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int. J. Neuropsychopharmacol. 2002, 5:389-399.
7. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
8. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Ann. Rev. Biochem. 2002, 71:635-700.
9. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmächer T. Cytokine-associated emotional and cognitive disturbance in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
10. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
11. Maric N.P., Adzic M. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits. Psychiatr. Danub. 2013, 25(3):299-305.
12. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987, 238:522-524.
13. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233:652-654.
14. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007, 21:9-19.
15. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 2004, 63:901-910.
16. Cassano P., Hidelgo A., Burgos V., Adris S., Argibay P. Hippocampal up-regulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). Pharmacogenomics J. 2006, 6:381-387.
17. Sun H., Sheveleva E., Xu B., Inoue H., Bowden T.G., Chen Q.M. Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta. Am. J. Physiol. Cell Physiol. 2008, 295:915-922.
18. Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr. Dis. Treat. 2009, 5:433-449.
19. Lapchak P.A., Araujo D.M., Hefti F. Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience 1993, 53:297-301.
20. Haddad J., Saade N.E., Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 2002, 133:1-19.
21. Porsolt R.D., Pichon M.L., Jalfre M. Depression: a new model sensitive to the antidepressant treatment. Nature 1977, 266:730-732.
22. Spasojevic N., Gavrilovic Lj, Dronjak S. Different behavioral effects of maprotiline and fluxilan in rats. Arch. Biol. Sci. 2008, 60:33-39.
23. Moutsatsou P., Psarra A.M., Tsiapara A., Paraskevakou H., Davaris P., Sekeris C.E. Localization of the glucocorticoid receptor in rat brain mitochondria. Arch. Biochem. Biophys. 2001, 386(1):69-78.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
26. Chen J., Evans A.N., Liu Y., Honda M., Saavedra J.M., Aguilera G. Maternal deprivation in rats is associated with corticotrophin-releasing hormone (CRH) promoterhypomethylation and enhances CRH transcriptional responses to stress in adulthood. J. Neuroendocrinol. 2012, 24(7):1055-1064.
27. Kino T., Jaffe H., Amin N.D., Chakrabarti M., Zheng Y.L., Chrousos G.P., Pan H.C. Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol. Endocrinol. 2010, 24:941-952.
28. Yu Y., Kang Y.M., Zhang Z.H., Wei S.G., Chu Y., Weiss R.M., Felder R.B. Increased cyclooxygenase-2 expression in hypothalamic paraventricular nucleus in rats with heart failure: role of nuclear factor kappaB. Hypertension 2007, 49(3):511-518.
29. Rutledge R., Cote C. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res. 2003, 31:e93.
30. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T))method. Methods 2001, 25:402-408.
31. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711:163-174.
32. Pitychoutis P.M., Nakamura K., Tsonis P.A., Papadopoulou-Daifoti Z. Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed. Neuroscience 2009, 159(4):1216-1232.
33. Maes M., Meltzer H.Y., Scharpe S., Cooreman W., Uyttenbroeck W., Suy E., Vandervorst C., Calabrese J., Raus J., Cosyns P. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res. 1993, 47:229-241.
34. Walker A.K., Budac D.P., Bisulco S., Lee A.W., Smith R.A., Beenders B., Kelley K.W., Dantzer R. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 2013, 38:1609-1616.
35. Spinedi E., Gaillard R.C., Chisari A. Sexual dimorphism of neuroendocrine-immune interactions. Neuroendocrine Immune Interactions 2002, 91-107. Karger, Basel, Switzerland. R.C. Gaillard (Ed.).
36. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79:1-71.
37. Pepels P.P., Bonga S.E., Balm P.H. Bacterial lipopolysaccharide (LPS) modulates corticotropin-releasing hormone (CRH) content and release in the brain of juvenile and adult tilapia (Oreochromis mossambicus; Teleostei). Exp. Biol. 2004, 207(Pt 25):4479-4488.
38. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987, 238:524-526.
39. Wu C.W., Chen Y.C., Yu L., Chen H., Jen C.J., Huang A.M., Tsai H.J., Chang Y.T., Kuo Y.M. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. J. Neurochem. 2007, 103:2471-2481.
40. Schnydrig S., Korner L., Landweer S., Ernst B., Walker G., Otten U., Kunz D. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotrophin and proopiomelanocortin in mouse brain. Neurosci. Lett. 2007, 429(1):69-73.
41. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry. 2006, 59:1116-1127.
42. Kunugi H., Hor iH, Adachi N., Numakawa T. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin. Neurosci. 2010, 64:447-459.
43. Cortese G.P., Barrientos R.M., Maier S.F., Patterson S.L. Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes. J. Neurosci. 2011, 31:4274-4279.
44. Guan Z., Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav. Immun. 2006, 20:64-71.
45. de Paiva V.N., Lima S.N., Fernandes M.M., Soncini R., Andrade C.A., Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav. Brain Res. 2010, 215(1):146-151.
46. Mouihate A., Pittman Q.J. Neuroimmune response to endogenous and exogenous pyrogens is differently modulated by sex steroids. Endocrinology 2003, 144:2454-2460.
47. Lei B., Mace B., Dawson H.N., Warner D.S., Laskowitz D.T., James M.L. Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLOS ONE 2014, 9(7):e103969. eCollection 2014. 10.1371/journal.pone.0103969.
48. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
49. Madrigal J.L., Hurtado O., Moro M.A., Lizasoain I., Lorenzo P., Castrillo A., Boscá L., Leza J.C. The increase in TNF-alpha levels is implicated in NF-kappa B activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002, 26(2):155-163.
50. Ma Y., Matsuwaki T., Yamanouchi K., Nishihara M. Cyclooxygenase-2-related signaling in the hypothalamus plays differential roles in response to various acute stresses. Brain Res. 2013, 1508:23-33.
51. Szatmáry Z., Garabedian M.J., Vilcek J. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J. Biol. Chem. 2004, 279:43708-43711.
52. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
53. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids-mechanisms for old drugs. N. Engl. J. Med. 2005, 353:1711-1723.
54. Zhao X., Zhang Y., Strong R., Zhang J., Grotta J.C., Aronowski J. Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappaB subunit, iNOS, and COX-2 expression. J. Neurochem. 2007, 101:652-663.
55. Roos A.B., Nord M. The emerging role of C/EBPs in glucocorticoid signaling: lessons from the lung. J. Endocrinol. 2012, 212(3):291-305.
56. Sun H., Sheveleva E., Xu B., Inoue H., Bowden T.G., Chen Q.M. Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta. Am. J. Physiol. Cell Physiol. 2008, 295(4):C915-C922.
57. Milatovic D., Montine T.J., Aschner M. Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity. Neurotoxicology 2011, 32:312-319.
58. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
59. Ejarque-Ortiz A., Medina M.G., Tusell J.M., Pérez-González A.P., Serratosa J., Saura J. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 2007, 55(2):178-188.
60. Kfoury N., Kapatos G. Identification of neuronal target genes for CCAAT/enhancer binding proteins. Mol. Cell. Neurosci. 2009, 40(3):313-327.